HLYK
HealthLynked Corp
-0.04 (-1.86%)2.16USD400成交股數6.4M市值–本益比(近四季)4.7股價營收比-57.8%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 250K-58% | 423K-45% | 310K-47% | 389K-51% | 592K-41% | 774K-71% | 590K-56% | 795K-53% | 1.0M | 2.7M | 1.3M | 1.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 517K | 847K | 454K | 501K | 452K | 629K | 632K | 861K | 999K | 918K | 768K | 834K |
| 營業利益 | −539K+24% | −701K+14% | −531K-68% | −530K-51% | −435K-63% | −617K-44% | −1.7M+41% | −1.1M+35% | −1.2M | −1.1M | −1.2M | −798K |
| 營業利益率 | -215.7% | -165.5% | -171.2% | -136.3% | -73.5% | -79.7% | -283.2% | -135.8% | -117.3% | -41.7% | -88.9% | -46.9% |
| 稅後淨利 | −820K+17% | −1.6M+54% | −676K-66% | −852K-45% | −701K-49% | −1.1M-18% | −2.0M+1028% | −1.5M+54% | −1.4M | −1.3M | −175K | −1.0M |
| 淨利率 | -328.1% | -382.9% | -218.1% | -219.2% | -118.3% | -135.7% | -334.4% | -193.7% | -138.2% | -48.2% | -13.1% | -58.9% |
| 稀釋 EPS | -0.28+12% | -0.56+51% | -0.24-66% | -0.30+2900% | -0.25 | -0.37+3600% | -0.70 | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| 稀釋股數 | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | 282M | 280M | 263M | 266M | 260M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 13K | 24K | 37K | 11K | 20K | 22K | 15K | 173K | 23K | 247K | 51K | 919K |
| 應收帳款 | – | – | – | – | – | – | 26K | 39K | 34K | 21K | 42K | 39K |
| 存貨 | 18K | 18K | 18K | 32K | 28K | 32K | 79K | 96K | 136K | 133K | 142K | 156K |
| 總資產 | 1.6M | 1.6M | 1.7M | 1.8M | 1.8M | 2.1M | 2.8M | 3.9M | 3.9M | 4.3M | 5.7M | 5.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.3M | 8.6M | 7.5M | 7.2M | 6.6M | 6.2M | 4.7M | 4.3M | 3.7M | 3.5M | 4.1M | 4.0M |
| 股東權益 | −7.8M | −7.0M | −5.8M | −5.4M | −4.8M | −4.1M | −1.9M | −425K | 221K | 805K | 1.6M | 1.6M |
| 負債比 | 586.7% | 531.9% | 438.5% | 407.9% | 357.1% | 301.1% | 170.1% | 111.0% | 94.3% | 81.2% | 72.6% | 75.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −222K-49% | – | – | – | −433K | – | – | −855K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 3K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −857K | – | – | – |
| 折舊攤銷 | 10K | 26K | 26K | 20K | 27K | 28K | 83K | 85K | 87K | 88K | 87K | 88K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -85.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.1M
| Health Services | 2.0M | 97.0% | -30.3% |
|---|---|---|---|
| Medical Distribution | 40K | 1.9% | -61.3% |
| Digital Healthcare | 23K | 1.1% | -30.2% |
產品／服務2025 年度 · 4.1M
| Patent Service Revenue Net | 2.0M | 48.5% | -30.3% |
|---|---|---|---|
| Patient Service Revenue Net | 2.0M | 48.5% | -30.3% |
| Product And Other Revenue | 40K | 1.0% | -61.3% |
| Product Revenue | 40K | 1.0% | -61.3% |
| Subscription Revenue | 23K | 0.5% | -30.2% |
| Subscription And Event Revenue | 23K | 0.5% | -30.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.1M | -31.3% | −3.3M | -158.8% | -1.16 | – |
| FY2024 | 3.0M | -47.4% | −6.1M | -203.8% | -2.18 | −3.5M |
| FY2023 | 5.7M | -2.3% | −1.0M | -17.7% | 0.00 | −4.1M |
| FY2022 | 5.9M | -9.8% | −8.8M | -150.5% | -0.04 | −4.4M |
| FY2021 | 6.5M | +5.9% | −10.4M | -160.3% | -0.05 | −3.8M |
| FY2020 | 6.1M | +52.6% | −5.8M | -93.8% | -0.04 | −2.1M |
| FY2019 | 4.0M | +77.9% | −5.5M | -137.6% | -0.06 | −2.4M |
| FY2018 | 2.3M | – | −5.8M | -256.3% | -0.07 | −2.4M |